Charles Cazanave Selected Research

Charles Cazanave Research Topics

16	Infections 11/2022 - 12/2010
5	Acquired Immunodeficiency Syndrome (AIDS) 01/2016 - 01/2008
4	Inflammation (Inflammations) 01/2021 - 01/2017
3	HIV Infections (HIV Infection) 07/2022 - 08/2011
3	Coinfection 01/2020 - 01/2014
2	Neoplasms (Cancer) 07/2022 - 01/2016
2	Communicable Diseases (Infectious Diseases) 04/2022 - 07/2013
2	Bacterial Infections (Bacterial Infection) 09/2021 - 12/2010
2	Lipodystrophy 06/2008 - 01/2008
1	Arthritis (Polyarthritis) 11/2022
1	COVID-19 10/2022
1	Progressive Multifocal Leukoencephalopathy 07/2022
1	Primary Immunodeficiency Diseases 07/2022
1	Sepsis (Septicemia) 04/2022
1	Reinfection 01/2022
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2022
1	Neurosyphilis (General Paresis of the Insane) 10/2021
1	Pneumonia (Pneumonitis) 09/2021
1	Lymphopenia (Lymphocytopenia) 09/2020
1	Measles 09/2020
1	Bacteremia 11/2019
1	Rupture 05/2019
1	Preterm Premature Rupture of the Membranes 05/2019
1	Persistent Infection 01/2019
1	Abscess 01/2018
1	Discitis 03/2016
1	Endocarditis 03/2016
1	Embolism (Embolus) 03/2016
1	Lymphocele 08/2015
1	Necrosis 04/2015
1	Septic Shock (Toxic Shock Syndrome) 04/2015
1	Erysipelas 02/2015
1	Thrombosis (Thrombus) 02/2015
1	False Aneurysm (Pseudoaneurysm) 02/2015
1	Diabetes Mellitus 08/2014
1	Osteomyelitis 08/2014
1	Hepatitis C 01/2014
1	Hypertension (High Blood Pressure) 01/2014
1	Heart Failure 12/2010
1	Insulin Resistance 06/2008
1	Osteoporosis 01/2008

7	Anti-Bacterial Agents (Antibiotics)IBA 11/2022 - 07/2013
4	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 09/2020 - 01/2017
2	SolutionsIBA 01/2022 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2016
2	Biological ProductsIBA 09/2020 - 01/2019
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 06/2019 - 02/2015
2	Doxycycline (Periostat)FDA LinkGeneric 01/2019 - 01/2018
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 10/2022
1	sotrovimabIBA 10/2022
1	Penicillin G (Benzylpenicillin)FDA LinkGeneric 10/2021
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 10/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2021
1	Immunoglobulin M (IgM)IBA 09/2020
1	Immunoglobulin G (IgG)IBA 09/2020
1	Uric Acid (Urate)IBA 01/2020
1	Nevirapine (Viramune)FDA Link 01/2020
1	Ertapenem (Invanz)FDA Link 12/2019
1	Oxytocin (Pitocin)FDA LinkGeneric 05/2019
1	AminoglycosidesIBA 05/2019
1	LE(2)IBA 05/2019
1	beta-LactamsIBA 05/2019
1	ProstaglandinsIBA 05/2019
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2019
1	Differentiation AntigensIBA 10/2015
1	CaspasesIBA 04/2015
1	Histones (Histone)IBA 04/2015
1	Polytetrafluoroethylene (Teflon)FDA Link 02/2015
1	ThymidineIBA 06/2008
1	LipidsIBA 06/2008

12	Therapeutics 11/2022 - 08/2011
4	Highly Active Antiretroviral Therapy (HAART) 01/2020 - 01/2008
3	Prostheses and Implants (Prosthesis) 08/2015 - 12/2010
2	Surgical Amputation (Amputations) 08/2014 - 12/2010
1	Organ Transplantation 07/2022
1	Central Venous Catheters 04/2022
1	Catheters 04/2022
1	Renal Dialysis (Hemodialysis) 04/2022
1	Endovascular Aneurysm Repair 01/2022
1	Length of Stay 10/2021
1	Activities of Daily Living (ADL) 11/2019
1	Intravenous Administration 05/2019
1	Induced Labor 05/2019
1	Blood Vessel Prosthesis 03/2016
1	Reoperation 02/2015
1	Arthroplasty 11/2012